痴呆患者入住养老院及死亡时间:系统综述与Meta分析
该系统综述与Meta分析纳入261项纵向研究,评估痴呆患者生存期及入住养老院时间。诊断时平均预期寿命随年龄变化:男性65岁5.7年至85岁2.2年,女性8.0年至4.5年;约三分之一余生在养老院度过,五年内超过半数入住养老院。
要点
- 诊断时中位生存期随年龄显著变化:女性平均60岁8.9年至男性平均85岁2.2年。
- 女性总体生存期较男性短4.1年(95%CI 2.1至6.1),归因于诊断年龄较晚。
- 入住养老院中位时间3.3年(四分位距1.9至4.0),诊断后第一年13%入住,五年时增至57%。
核心结论
- 痴呆患者诊断时平均预期寿命男性65岁5.7年至85岁2.2年,女性65岁8.0年至85岁4.5年。
- 约三分之一余生在养老院度过,诊断后五年内超过半数入住养老院。
- 痴呆诊断后预后高度依赖个人及临床特征,为个体化预后信息及照护规划提供可能。
研究设计与样本
- 系统综述与Meta分析,检索Medline、Embase、Web of Science、Cochrane及Google Scholar自建库至2024年7月4日。
- 纳入261项符合标准的纵向研究,排除样本量少于150例、急性住院期间招募或随访不足一年的研究。
- 235项研究报告生存期共5 553 960名参与者,79项报告入住养老院共352 990名参与者。
主要发现
- 诊断时中位生存期强烈依赖年龄:女性平均60岁8.9年至男性平均85岁2.2年。
- 女性总体生存期较男性短,平均差异4.1年(95%CI 2.1至6.1),归因于女性诊断年龄较晚。
- 亚洲中位生存期较美国及欧洲长1.2至1.4年,阿尔茨海默病较其他类型痴呆长1.4年。
- 与2000年前研究相比,当代临床为基础研究中生存期更长(Ptrend=0.02),社区为基础研究则无此差异。
- 报告的临床特征及研究方法学差异共解释生存期异质性的51%。
局限性
- 评估入住率时,少数研究恰当考虑了竞争性死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To summarise available evidence on time to nursing home admission and death among people with dementia, and to explore prognostic indicators. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Embase, Web of Science, Cochrane, and Google Scholar from inception to 4 July 2024. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Longitudinal studies on survival or nursing home admission in people with dementia. Studies with fewer than 150 participants, recruitment during acute hospital admission, or less than one year of follow-up were excluded. RESULTS: 19 307 articles were identified and 261 eligible studies included. 235 reported on survival among 5 553 960 participants and 79 reported on nursing home admission among 352 990 participants. Median survival from diagnosis appeared to be strongly dependent on age, ranging from 8.9 years at mean age 60 for women to 2.2 years at mean age 85 for men. Women overall had shorter survival than men (mean difference 4.1 years (95% confidence interval 2.1 to 6.1)), which was attributable to later age at diagnosis in women. Median survival was 1.2 to 1.4 years longer in Asia than in the US and Europe, and 1.4 years longer for Alzheimer's disease compared with other types of dementia. Compared with studies before 2000, survival was longer in contemporary clinic based studies (Ptrend=0.02), but not in community based studies. Taken together, variation in reported clinical characteristics and study methodology explained 51% of heterogeneity in survival. Median time to nursing home admission was 3.3 years (interquartile range 1.9 to 4.0). 13% of people were admitted in the first year after diagnosis, increasing to 57% at five years, but few studies appropriately accounted for competing mortality risk when assessing admission rates. CONCLUSIONS: The average life expectancy of people with dementia at time of diagnosis ranged from 5.7 years at age 65 to 2.2 at age 85 in men and from 8.0 to 4.5, respectively, in women. About one third of remaining life expectancy was lived in nursing homes, with more than half of people moving to a nursing home within five years after a dementia diagnosis. Prognosis after a dementia diagnosis is highly dependent on personal and clinical characteristics, offering potential for individualised prognostic information and care planning. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42022341507.
引用
- Brück CC, Mooldijk SS, Kuiper LM, et al. Time to nursing home admission and death in people with dementia: systematic review and meta-analysis. BMJ. 2025. PMID: 39778977. doi:10.1136/bmj-2024-080636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。